Keywords: pozen, rocked, delay, migraine, drug, shares, firm

Pozen rocked by delay to migraine drug

Article | 30 January 2001

Print This

Shares in US firm Pozen lost almost half their value on January 26 afterthe US Food and Drug Administration asked for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in